Current disease status-In remission - Page 5 of 7 Posts on Medivizor
Navigation Menu

Current disease status-In remission Posts on Medivizor

Haemoptysis predicts survival and recurrence

Haemoptysis predicts survival and recurrence

Posted by on Oct 1, 2013 in Lung cancer | 0 comments

In a nutshell This study investigated the prognostic role of haemoptysis in patient diagnosed with adenocarcinoma of lung and cured after surgery. Some background Haemoptysis, or bloody sputum, is a common symptom of lung cancer. Haemoptysis is thought to occur due to the invasion of the cancer into the small blood vessels of the lung. Therefore,...

Read More

Adherence to trastuzumab therapy

Adherence to trastuzumab therapy

Posted by on Sep 28, 2013 in Breast cancer | 0 comments

In a nutshell This study evaluated the use, effects and adherence of trastuzumab (herceptin) as treatment for patients with breast cancer. Some background Trastuzumab is often prescribed as adjuvant (additional) therapy for human epidermal growth factor receptor-2 positive (HER2+) breast cancer. HER2 is a protein found on the surface of some...

Read More

Better surveillance to detect early recurrence

Better surveillance to detect early recurrence

Posted by on Sep 28, 2013 in Melanoma | 0 comments

In a nutshell This study evaluated whether there are specific, high-risk periods a melanoma can return (recur) and spread to distant organs of the body (metastasize). Some background Melanoma is a type of skin cancer that originates in the melanocytes (pigment producing cells of the skin). Often, particularly in the early stages, when the melanoma...

Read More

What features of colorectal cancer can predict return of the cancer?

What features of colorectal cancer can predict return of the cancer?

Posted by on Sep 12, 2013 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the characteristics of colorectal cancer recurrence (return of the cancer) within 5 years and after 5 years of follow-up after initial curative surgery. Some background In patients with colorectal cancer (CRC), removal of all cancer cells and a small amount of healthy tissue around the cancer when it appears to...

Read More

The prevention of bone loss in prostate cancer patients undergoing ADT

The prevention of bone loss in prostate cancer patients undergoing ADT

Posted by on Sep 10, 2013 in Prostate cancer | 0 comments

In a nutshell This study evaluated the use of alendronate (Fosamax) for the prevention of bone loss in men undergoing androgen deprivation therapy (ADT) for localized prostate cancer. Some background Androgens are a group of hormones (including testosterone) which can stimulate the growth and spread of prostate cancer cells. Androgen deprivation...

Read More

Does obesity influence how breast cancer patients will benefit from further hormonal therapy?

Does obesity influence how breast cancer patients will benefit from further hormonal therapy?

Posted by on Aug 20, 2013 in Breast cancer | 0 comments

In a nutshell This article investigated whether the body mass index or BMI (defined as weight divided by the square of height) can be used to determine how a patient with breast cancer treated with hormonal therapy may benefit from further treatment with a type of hormonal therapy called aromatase inhibitors. Some background Aromatase inhibitors...

Read More

Evaluating outcomes after a local recurrence following breast conserving surgery in young breast cancer patients

Evaluating outcomes after a local recurrence following breast conserving surgery in young breast cancer patients

Posted by on Aug 15, 2013 in Breast cancer | 0 comments

In a nutshell This study evaluated survival rates after a local recurrence (return of the cancer close to the place of the initial cancer) in young breast cancer patients treated with breast conserving surgery. Some background Young patients with early stage breast cancer are usually treated with breast conserving surgery or BCS (removal of the...

Read More

20-year survival rates among patients with thin melanomas

20-year survival rates among patients with thin melanomas

Posted by on Jul 10, 2013 in Melanoma | 0 comments

In a nutshell This study determined the 20 year survival rate for patients with thin melanomas. This study also looked at likely factors that might influence survival. Some background Thin melanomas measure less than 1.00 mm in diameter, and are considered an early stage of melanoma formation. Melanoma can generally be treated successfully with...

Read More

Evaluating the benefits of short term hormone therapy plus radiation therapy in patients with prostate cancer

Evaluating the benefits of short term hormone therapy plus radiation therapy in patients with prostate cancer

Posted by on Jul 5, 2013 in Prostate cancer | 0 comments

In a nutshell This article looked at the benefit on survival of short term hormone therapy called androgen deprivation therapy (ADT), in combination with radiation therapy, for the treatment of patients with prostate cancer.  Some background Prostate specific antigen (PSA) is a protein produced by the prostate gland. Men with a healthy...

Read More